The 4th Annual Precision CRISPR Congress Boston brought together large pharma, biotech, leading academia and technology providers.
Case study presentations focused on how to ensure your CRISPR workflows are customized, minimize off-target effects and overcome key delivery challenges.
This event gave attendees the chance to join the conversation with market leaders and innovators to cut through the avalanche of publications and extract maximum value from CRISPR genome engineering.
This industry defining meeting focused on making the most of greatest biotechnological breakthrough in a generation!
Horizon Discovery Group sponsored this event and Product Manager, James Goldmeyer, PhD gave a talk.
James presented our work on CRISPR-Cas9 mediated transactional activation (i.e. CRISPRa) using synthetic crRNA at this meeting. Attendees of the talk learnt how CRISPR-Cas9 gene knockout and activation in one-gene-per-well format allows for study of biological mechanisms in complex assays.